OpenBilldrug price receipt

NADAC week of 2026-10-14

INZIRQO 10 MG/ML ORAL SUSP

FDA nonproprietary name: hydrochlorothiazide

For 80 mL

Pharmacies pay

$356.94 filed

80 × $4.46172 per ML

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$415.48 estimated

$356.94 + $53.54 (15%) + $5.00 fee per fill = $415.48

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

INZIRQO 10 MG/ML ORAL SUSP is how the CMS NADAC file names this product. The FDA NDC Directory lists it as hydrochlorothiazide, under the trade name “INZIRQO”.

FDA gives its dosage form as powder, for suspension and its route as oral.

The labeler, the company named on the label, is ANI Pharmaceuticals, Inc.

FDA’s Established Pharmacologic Class for it is Thiazide Diuretic.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 70954-0522-10.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $356.94 for 80 mL (80 × $4.46172 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

The NDC

Other strengths, forms and brands

4 other products in the NADAC file share the FDA nonproprietary name hydrochlorothiazide with INZIRQO 10 MG/ML ORAL SUSP.

ProductPharmacies pay per unitMedicare per unit
HYDROCHLOROTHIAZIDE 12.5 MG CP
generic · capsule, gelatin coated / capsule
$0.02754 per EA filed
eff. 2026-09-23
$0.05843 per EA filed
Part D 2024 average
HYDROCHLOROTHIAZIDE 12.5 MG TB
generic · tablet
$0.03397 per EA filed
eff. 2026-09-23
$0.05843 per EA filed
Part D 2024 average
HYDROCHLOROTHIAZIDE 25 MG TAB
generic · tablet
$0.01153 per EA filed
eff. 2026-09-23
$0.05843 per EA filed
Part D 2024 average
HYDROCHLOROTHIAZIDE 50 MG TAB
generic · tablet
$0.03165 per EA filed
eff. 2026-09-23
$0.05843 per EA filed
Part D 2024 average
INZIRQO 10 MG/ML ORAL SUSP this page
brand · powder, for suspension
$4.46172 per ML filed
eff. 2026-09-23
We don’t know yet

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why does this page start at 80 mL?
NADAC prices this product per ML. The FDA NDC Directory’s package description gives 80 mL in one package for this product’s NDC (“80 mL in 1 BOTTLE (70954-522-10)”), so the card starts at one package: 80 ML. Change it to match your prescription.